From: Impact of self-reported physical activity and health promotion behaviors on lung cancer survivorship
Participant characteristic | Non-physically active (N = 331) | Physically active (N = 1135) | Total (N = 1466) |
---|---|---|---|
Age at diagnosis | Â | Â | Â |
  N | 331 | 1135 | 1466 |
 Mean (SD) | 68.7 (9.73) | 64.9 (10.82) | 65.7 (10.7) |
 Range | (35.0–91.0) | (18.0–93.0) | (18–93) |
Gender | Â | Â | Â |
 Female | 158 (47.7 %) | 568 (50 %) | 726 (49.5 %) |
 Male | 173 (52.3 %) | 567 (50 %) | 740 (50.5 %) |
Race | Â | Â | Â |
 Caucasian | 311 (94 %) | 1059 (93.3 %) | 1370 (93.5 %) |
 Hispanic | 4 (1.2 %) | 8 (0.7 %) | 12 (0.8 %) |
 Alaskan/Indian | 15 (4.5 %) | 54 (4.8 %) | 69 (4.7 %) |
 Black | 1 (0.3 %) | 3 (0.3 %) | 4 (0.3 %) |
 Asian/Pacific Islander | 0 (0.0 %) | 6 (0.5 %) | 6 (0.4 %) |
 Unknown | 0 (0.0 %) | 5 (0.4 %) | 5 (0.3 %) |
Years of schooling completed | Â | Â | Â |
 N | 67 | 307 | 374 |
 Mean (SD) | 13.0 (2.35) | 13.6 (2.41) | 13.5 (2.4) |
 Range | (6.0–17.0) | (5.0–18.0) | (5.0–18.0) |
Marital status | Â | Â | Â |
 Missing | 62 | 185 | 247 |
 Single | 9 (3.3 %) | 47 (4.9 %) | 56 (4.6 %) |
 Married | 194 (72.1 %) | 751 (79.1 %) | 945 (77.5 %) |
 Divorced | 27 (10 %) | 75 (7.9 %) | 102 (8.4 %) |
 Widowed | 39 (14.5 %) | 75 (7.9 %) | 114 (9.4 %) |
 Life partner | 0 (0.0 %) | 2 (0.2 %) | 2 (0.2 %) |
Vital status (as of 2/2010) | Â | Â | Â |
 Alive | 167 (50.5 %) | 787 (69.3 %) | 954 (65.1 %) |
 Dead | 164 (49.5 %) | 348 (30.7 %) | 512 (34.9 %) |
Time to last FU (as of 2/2010) in years | Â | Â | Â |
 N | 331 | 1135 | 1466 |
 Mean (SD) | 2.7 (2.15) | 3.3 (2.43) | 3.1 (2.38) |
 Range | (0.1–8.6) | (0.0–9.0) | 2.2 |
Cigarette smoking status | Â | Â | Â |
 Never | 36 (10.9 %) | 218 (19.2 %) | 254 (17.3 %) |
 Former smoker | 165 (49.8 %) | 615 (54.2 %) | 780 (53.2 %) |
 Current smoker | 129 (39 %) | 294 (25.9 %) | 423 (28.9 %) |
 Some smoking history | 1 (0.3 %) | 8 (0.7 %) | 9 (0.6 %) |
Pack-Years | Â | Â | Â |
 N | 292 | 910 | 1202 |
 Mean (SD) | 53.2 (34.44) | 45.4 (28.29) | 47.3 (30.07) |
 Range | (0.5–208.0) | (0.0–180.0) | (0.0–208.0) |
Condensed grade | Â | Â | Â |
 Missing | 1 | 6 | 7 |
 1 = Well differentiated | 58 (17.6 %) | 328 (29.1 %) | 386 (26.5 %) |
 2 = Moderately differentiated | 104 (31.5 %) | 414 (36.7 %) | 518 (35.5 %) |
 3 = Poorly differentiated | 142 (43 %) | 321 (28.4 %) | 463 (31.7 %) |
 4 = Non-gradeable | 26 (7.9 %) | 66 (5.8 %) | 92 (6.3 %) |
Stage | Â | Â | Â |
 Missing | 6 | 5 | 11 |
 Limited | 27 (8.3 %) | 36 (3.2 %) | 63 (4.3 %) |
 Extensive | 22 (6.8 %) | 30 (2.7 %) | 52 (3.6 %) |
 Stage IA | 49 (15.1 %) | 320 (28.3 %) | 369 (25.4 %) |
 Stage IB | 48 (14.8 %) | 186 (16.5 %) | 234 (16.1 %) |
 Stage IIA | 6 (1.8 %) | 24 (2.1 %) | 30 (2.1 %) |
 Stage IIB | 17 (5.2 %) | 68 (6 %) | 85 (5.8 %) |
 Stage IIIA | 42 (12.9 %) | 124 (11 %) | 166 (11.4 %) |
 Stage IIIB | 45 (13.8 %) | 116 (10.3 %) | 161 (11.1 %) |
 Stage IV | 69 (21.2 %) | 226 (20 %) | 295 (20.3 %) |
T (tumor) of TNM staging | Â | Â | Â |
 Missing | 69 | 176 | 245 |
 No primary tumor | 6(2.3 %) | 10(1.0 %) | 16(1.3 %) |
 Tumor < = 3 cm | 83 (31.7 %) | 420 (43.8 %) | 503 (41.2 %) |
 Tumor > 3 cm | 92 (35.1 %) | 309 (32.2 %) | 401 (32.8 %) |
 Invades chest wall | 14 (5.3 %) | 54 (5.6 %) | 68 (5.6 %) |
 Invades mediastinum | 56 (21.4 %) | 137 (14.3 %) | 193 (15.8 %) |
 Cannot be assessed | 11 (4.2 %) | 29 (3 %) | 40 (3.3 %) |
N (nodes) of TNM staging | Â | Â | Â |
 Missing | 51 | 123 | 174 |
 No nodal mets | 122 (43.6 %) | 611 (60.4 %) | 733 (56.7 %) |
 In Peribr/Hilar | 30 (10.7 %) | 98 (9.7 %) | 128 (9.9 %) |
 In Medias/Subcarinal | 97 (34.6 %) | 210 (20.8 %) | 307 (23.8 %) |
 Mets in contralaterl | 22 (7.9 %) | 76 (7.5 %) | 98 (7.6 %) |
 Nodes Unassessable | 9 (3.2 %) | 17 (1.7 %) | 26 (2 %) |
Surgery | Â | Â | Â |
 Missing | 12 | 27 | 39 |
 No | 179 (56.1 %) | 381 (34.4 %) | 560 (39.2 %) |
 Yes | 140 (43.9 %) | 727 (65.6 %) | 867 (60.8 %) |
Surgery within 6Â months | Â | Â | Â |
 Missing | 12 | 27 | 39 |
 No | 189 (59.2 %) | 435 (39.3 %) | 624 (43.7 %) |
 Yes | 130 (40.8 %) | 673 (60.7 %) | 803 (56.3 %) |
Chemotherapy | Â | Â | Â |
 Missing | 12 | 27 | 39 |
 No | 120 (37.6 %) | 542 (48.9 %) | 662 (46.4 %) |
 Yes | 199 (62.4 %) | 566 (51.1 %) | 765 (53.6 %) |
Chemotherapy within 6Â months | Â | Â | Â |
 Missing | 12 | 27 | 39 |
 No | 166 (52 %) | 686 (61.9 %) | 852 (59.7 %) |
 Yes | 153 (48 %) | 422 (38.1 %) | 575 (40.3 %) |
Radiation | Â | Â | Â |
 Missing | 12 | 27 | 39 |
 No | 193 (60.5 %) | 769 (69.4 %) | 962 (67.4 %) |
 Yes | 126 (39.5 %) | 339 (30.6 %) | 465 (32.6 %) |
Radiation within 6Â months | Â | Â | Â |
 Missing | 12 | 27 | 39 |
 No | 230 (72.1 %) | 875 (79 %) | 1105 (77.4 %) |
 Yes | 89 (27.9 %) | 233 (21 %) | 322 (22.6 %) |